23 May 2013
Keywords: Stimuvax, Lung cancer vaccine, Merck Serono, Merck KGaA, FDA,
Article | 18 June 2010
Following a decision by the US Food and Drug Administration to lift a clinical hold imposed on trails of Merck ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 June 2010
© 2013 thepharmaletter.com